FDA Issued AnnouncementDear Healthcare Practitioner:This is to alert you to reports of deaths associated with the use of radio frequency (RF) ablation devices during lung tumor ablation.Public health concernsFDA has received reports of patient deaths associated with lung tumor ablation using RF ablation devices, and similar reports have appeared in the literature.1,2,3,4 Patient selection, subsequent treatment, and technical use of the RF device, including placement and operation, may have contributed to the fatalities.
